Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:57 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 721–744 of 1,487 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Down Syndrome, Trisomy 21
Interventions: EXPO, EXPO Extended, EXPO Foundations; Behavioral
Lead sponsor: Colorado State University; Other
Eligibility: 36 Months to 72 Months
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: HIV/AIDS
Interventions: Enhanced Peer Intervention; Behavioral
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older
Enrollment: 348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 3
States / cities: Miami, Florida • Boston, Massachusetts • Brooklyn, New York

Conditions: Systemic Lupus Erythematosus, Quality of Life, Behavior, Health
Interventions: Peer Mentoring, Social Support Group; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older · Female only
Enrollment: 314 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Breastfeeding, Exclusive
Interventions: MILC application, Usual care; Behavioral
Lead sponsor: Benten Technologies, Inc.; Industry
Eligibility: 18 Years to 44 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 3
States / cities: Farmington, Connecticut • Research Triangle Park, North Carolina • Philadelphia, Pennsylvania

Conditions: Health Care Utilization
Interventions: No Message, Standard message, Tailored message; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 6 Years to 17 Years
Enrollment: 945 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Trauma Injury
Interventions: Standard of Care (acetaminophen +naproxen +gabapentin + as needed oxycodone or Tramadol), Dronabinol; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 16 Years to 80 Years
Enrollment: 484 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Latent Tuberculosis
Interventions: Regularly scheduled LTBI medication reminder text messages; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Concussion (Diagnosis), Concussion, Mild Traumatic Brain Injury, Treatment, Sleep Health, Depression, Anxiety
Interventions: Sleep Intervention; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 10 Years to 19 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Orthopaedic Trauma, Chronic Opioid Use
Interventions: Ketorolac Injection, Standard of Care (SOC) Multimodal Analgesia; Drug · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 458 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts • Nashville, Tennessee

Conditions: Deep Venous Thrombosis
Interventions: Desirudin (Iprivask™), Heparin; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Covid19, Vaccine Refusal
Interventions: Behavioral economics; Behavioral
Lead sponsor: VA Puget Sound Health Care System; Federal
Eligibility: 18 Years and older
Enrollment: 4,311 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Multiple Myeloma
Interventions: BCMA CART + huCART19, CART BCMA or CART BCMA + huCART19, Single-dose infusion of CART BCMA or CART BCMA + huCART19; Biological
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2036
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Eye Diseases
Interventions: Automated Telephone System, Personalized Telephone Call, Usual Care; Behavioral
Lead sponsor: Wills Eye; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: Pre-Visit Patient Text Message, Post-Visit Patient Text Messages, Smart Data Element (SDE); Behavioral
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 40 Years to 74 Years · Female only
Enrollment: 8,490 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Lancaster, Pennsylvania

Conditions: Osteoarthritis Nos, of Sacroiliac Joint
Interventions: Cooled RFA of sacral lateral branches; Procedure
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: AML
Interventions: Volasertib, Cytarabine, Idarubicin, Bone Marrow Biopsy; Drug · Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Substance Use Disorders
Interventions: Voucher Reinforcement, Standard Control; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chronic Thromboembolic Pulmonary Hypertension
Interventions: Selexipag, Placebo; Drug
Lead sponsor: Actelion; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 32
States / cities: La Jolla, California • Los Angeles, California • Aurora, Colorado + 25 more

Conditions: Pancreatic Neoplasms, Pancreatic Cancer
Interventions: Gemcitabine, Cisplatin; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Smoking Cessation
Interventions: RITCh Treatment, Standard Treatment; Behavioral
Lead sponsor: The City College of New York; Other
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: ACL Tear, Post Operative Pain
Interventions: Iovera, Celecoxib, Acetaminophen, Oxycodone, Tramadol, Bupivacaine Hydrochloride, Acetaminophen 500Mg Cap; Device · Drug
Lead sponsor: Matthew Varacallo; Other
Eligibility: 15 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: DuBois, Pennsylvania

Conditions: Idiopathic Hyperbilirubinemia, Neonatal Hyperbilirubinemia, Prematurity
Interventions: Phototherapy, glycerin suppository; Procedure · Drug
Lead sponsor: University of Rochester; Other
Eligibility: 30 Weeks to 35 Weeks
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Narcotic Use, Pain, Constipation, Nausea
Interventions: Celebrex, Gabapentin, IV acetaminophen, oral acetaminophen, oral ibuprofen, percocet, vicodin, Oxycodone, dilaudid, Dexamethasone, zofran; Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 138 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: CRC Screening, CRC (Colorectal Cancer)
Interventions: Digital Outreach, In Person consultation; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 45 Years to 75 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Search by objective public record fields.

Executive Function Play Opportunities for Children With Down Syndrome

Minority AIDS Initiative Retention and Re-Engagement Project

Peer Approaches to Lupus Self-management

MILC: A Comprehensive Mobile Application That Addresses the Breastfeeding Challenges of Low-income Hispanic Mothers

Effect of Varied Outreach Methods on Appointment Scheduling and Appointment Completion Using MyChart

Dronabinol On the Pain Experience

Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging

Multidimensional Sleep Health Intervention to Optimize Concussion Recovery

Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients

Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery

VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans

Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma

Improving Follow-Up Adherence in a Primary Eye Care Setting

Increasing Screening for Cancer Using EHR-Nudges Replication

Optimal Performance of RFA of the Nerves Supplying the Posterior Sacroiliac Joint Complex.

Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia

Treatment for Psychological and Drug Abuse Problems

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision

RITCH: Reducing Disparities in Tobacco Cessation Outcomes

Impact of Opioid Avoidance Protocol for ACL Reconstruction

Glycerin Suppositories to Reduce Jaundice in Premature Infants

Decreasing Narcotics in Advanced Pelvic Surgery

Improving Rates of Diagnostic Colonoscopy in Native Americans